Asch
Paris, 75019, France
NCT Number: NCT02400541
The aim of research is to test in a randomized clinical trial with active sessions, the efficacy of cognitive remediation therapy in children anorexia nervosa compared to a controlled group. The investigators want to confirm the efficacy of cognitive remediation treatment in children's flexibility problems.
Looking for future studies?
Notify Me8 year–16 year
Female
Interventional
Not applicable
Paris, 75019, France
In this research, the investigators want to evaluate remediation cognitive therapy in anorexia nervosa compared to a controlled group (relaxation) based on different factors that testified the cognitive improvement of patients: one week after therapy, six months after and one year after.
Those factors are:
Weight, perfectionism and food symptomatology, temperament, therapeutic alliance and change motivation, clinical evolution of anorexia nervosa, self esteem, executive functions, neuropsychological performance (flexibility and central coherence).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Our scheme comprises 10 biweekly sessions ( 5 in group and 5 single) . Each session last about 45 minutes.
Individual sessions will be held with the patient and a therapist trained in the CRT; group sessions will be led by two therapists trained in CRT and regroup the maximum 5 patients.
Our scheme comprises 10 biweekly sessions. Each session last about 45 minutes.
Time frame: 6 months after therapy
behavioral characteristics related to cognitive difficulties flexibility of anorexic patients, as measured in the medium term (6 months post treatment) by the score of the subscale "shift" BRIEF parent version of the scale (BRIEF-PR).
Time frame: 6 months and one year
Assess the impact of cognitive remediation therapy on :Weight status by the Body Mass Index
Time frame: 6 months and one year
Assess the impact of cognitive remediation therapy on :Food symptoms and perfectionism measured by the Eating Disorders Inventory auto questionnaire, EDI-2
Time frame: 6 months after therapy
Assess the impact of cognitive remediation therapy on :Temperamental profile measured by the Junior Temperament and Character Inventory questionnaire
Time frame: 6 months and one year
Assess the impact of cognitive remediation therapy on : therapeutic alliance and motivation to change measured by self-reported scales Helping Alliance Questionnaire-11 and MOTIV
Time frame: 6 months and one year
measured by the Rosenberg Self-Esteem Scale
Time frame: 6 months and one year
measured by the scale BRIEF-Parent Report
Time frame: 6 months and one year
measured by tests of WCST (Wisconsin Card Sorting Test), Geft (Group Embedded Figure Test) and tests the battery Ravello Profile (Tower, Verbal Fluency Test VFT, Trail Making Test TMT, Rey Complex Figure Test Osterreich ROCFT )
Looking for future studies?
Notify MeAssistance Publique - Hôpitaux de Paris
Other
Prospective Evaluation of Neuropsychological and Clinical Impact of Cognitive Remediation Program Among Children and Adolescents Treated for Anorexia Nervosa
Acronym: RECOGAMEA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06085092
Anorexia Nervosa, Eating Disorders
Hershey, Pennsylvania, United States
View Trial DetailsNCT02381639
Anorexia Nervosa, Feeding and Eating Disorders
Nantes, France
View Trial DetailsNCT07098156
Anorexia Nervosa, Autism
Aberdeen, Aberdeen City, United Kingdom
View Trial DetailsNCT05596799
Anorexia Nervosa, Anorexia Nervosa in Remission
Louisville, Kentucky, United States
View Trial Details